IJMS | Free Full-Text | Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
κ-opioid receptor - Wikipedia
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Structure of the human κ-opioid receptor in complex with JDTic | Nature
κ-opioid receptor - Wikipedia
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | SpringerLink
Kappa Receptors – Opioid Peptides
PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age | Neuropsychopharmacology
Opioid Receptor | kappa, mu Opioid Receptor
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development | National Institute on Drug Abuse (NIDA)
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Opioids in cancer: The κ‑opioid receptor (Review)
